THE MCMANUS GROUP for DENDREON PHARMACEUTICALS LLC
What was lobbied
One issue area, each in the filer's own words, with who lobbied on it and where.
Medicare/Medicaid MMM
Access to Part B drugs. Extension to Medicare sequester delay in S. 748 - A Bill to Provide for an Extension of the Temporary Suspension of Medicare Sequestration During the COVID-19 Public Health Emergency, H.R. 1868 - To Prevent Across-The-Board Direct Spending Cuts, and For Other Purposes, H.R. 315 - Medicare Sequester COVID Moratorium Act and H.R.1999 - To delay and offset the sequester under the Statutory Pay-As-You-Go Act of 2010 as a result of the enactment of the American Rescue Plan Act of 2021, and for other purposes.
Foreign entity interest: Dendreon is a subsidiary of Nanjing Xinjiekou Department Store, Co. Ltd. in China.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JOHN MCMANUS | LA, Bill Thomas. Staff Director, W&M Health Subcommittee |
| ALANNA TEMME | LD, Rep. Jon Porter |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.